ArticleBiology2026
Effects of Hypomagnetic Field Environment on Tumor Progression and Gut Microbiota in LLC Tumor-Bearing Mice.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The tumor microenvironment interacts bidirectionally with systemic host factors, including the gut microbiota. However, it remains unclear whether physical environmental stimuli, such as a hypomagnetic field (HMF), can modulate tumor progression and associated microbial features. In this study, C57BL/6 mice bearing subcutaneous Lewis lung carcinoma (LLC) were maintained under geomagnetic field (GMF) or HMF conditions. We evaluated tumor growth and systemic toxicity, and analyzed fecal samples using 16S rRNA sequencing and short-chain fatty acid (SCFA) profiling. Compared with the GMF control, HMF exposure significantly reduced tumor growth, with an approximately 40% decrease in endpoint tumor volume. No obvious systemic toxicity was detected by monitoring body weight, serum biochemical parameters, and organ histology. HMF exposure altered gut microbial diversity and community composition, with enrichment of several Clostridia-related lineages. Fecal SCFA analysis revealed increased butyrate levels in the HMF group (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.